Major orthopedic joint replacement implants include hip and knee joint replacements, which are surgical procedures that aim to relieve pain and restore function. 3D printing technologies have become increasingly prevalent in the healthcare industry as a treatment procedure to enhance the speed and effectiveness of joint surgery. Major companies such as Stryker, Johnson and Johnson and Zimmer have launched implants which use 3D printing technology to provide customized surgery for their patients. This is done by replicating components used in the surgery by using patient’s X-rays images or CT scan which thereby reduce the risk of a wrong fit. For instance, in 2018, the US Food and Drug Administration (US FDA) approved Stryker Corporation’s Tritanium® TL Curved Posterior Lumbar Cage, which uses 3D-printed interbody fusion cage that acts as a support during the lumbar fixation during surgery. The Tritanium TL Curved Posterior Lumbar Cage is a hollow implant that consists of both solid and porous structures, built simultaneously using AMagine, an approach to implant creation using additive manufacturing, also known as 3D printing. Also, in 2017, ConforMIS, a medical technology company that develops and sells joint replacement implants, announced clearance from the FDA for its iTotal Hip System which comprises of single use technology and 3D-printed instruments to provide customized hip replacement to patients.
Major orthopedic companies are also increasingly adopting robotic technologies to increase efficiency and reduce the failure rate of knee surgery. Robots help in reducing the time of surgical procedures and offer better results by eliminating the risks of complications. Companies such as Stryker and Smith and Nephew believe that robots give them an edge in the major orthopedic replacement implants market. For instance, in 2017, Stryker Corporation launched the MAKO robot which is enabled to perform total knee replacement in the US. In 2016, Smith and Nephew launched its Navio surgical robot to perform knee replacement surgery in the US. The robot, which initially performed partial knee surgery, conducted its first full knee replacement surgery in New York and was given an approval by the US FDA.
The global major orthopedic joint replacement implants market, valued at $17.1 billion in 2018, is expected to grow to $20.1 billion in 2022, at an annual growth rate of more than 3.5%.
Technological advances such as 3D printing, automation, and robotics are expected to drive the major orthopedic replacement implants market during the forecast period. These technologies help to increase efficiency, reduce the time of surgical procedures, and provide personalized care to patients suffering from joint disorders.